scispace - formally typeset
A

Akinobu Ito

Researcher at Hokkaido University

Publications -  18
Citations -  1377

Akinobu Ito is an academic researcher from Hokkaido University. The author has contributed to research in topics: Biofilm & Escherichia coli. The author has an hindex of 10, co-authored 17 publications receiving 1014 citations.

Papers
More filters
Journal ArticleDOI

Increased Antibiotic Resistance of Escherichia coli in Mature Biofilms

TL;DR: It is likely that the observed resistance of bioFilms can be attributed to formation of ampicillin-resistant subpopulations in the deeper layers of mature biofilms but not in young colony biofilm and that the production and resistance of the subpopulation were aided by biofilm-specific phenotypes, like slow growth and induction of rpoS-mediated stress responses.
Journal ArticleDOI

Siderophore Cephalosporin Cefiderocol Utilizes Ferric Iron Transporter Systems for Antibacterial Activity against Pseudomonas aeruginosa

TL;DR: It is concluded that cefIDERocol forms a chelating complex with iron, which is actively transported into P. aeruginosa cells via iron transporters, resulting in potent antibacterial activity of cefiderocol against P.aerug inosa.
Journal ArticleDOI

In vitro antibacterial properties of cefiderocol, a novel siderophore cephalosporin, against Gram-negative bacteria

TL;DR: Cefiderocol, a novel parenteral siderophore cephalosporin conjugated with a catechol moiety, has a characteristic antibacterial spectrum with a potent activity against a broad range of aerobic Gram-negative bacterial species, including carbapenem-resistant strains of Enterobacteriaceae and nonfermenting bacteria such as Pseudomonas aeruginosa and Acinetobacter baumannii.
Journal ArticleDOI

In Vitro Antimicrobial Activity of a Siderophore Cephalosporin, S-649266, against Enterobacteriaceae Clinical Isolates, Including Carbapenem-Resistant Strains

TL;DR: This is the first report to demonstrate that S-649266, a novel siderophore cephalosporin, has significant antimicrobial activity against Enterobacteriaceae, including strains that produce carbapenemases such as KPC and NDM-1.
Journal ArticleDOI

Stability of Novel Siderophore Cephalosporin S-649266 against Clinically Relevant Carbapenemases

TL;DR: Its stability against clinically relevant carbapenemases was investigated and NDM-1 hydrolyzed meropenem 3-fold faster than S-649266 at 200 μM.